WHC is still in active development. Read this to understand our approach.
depiction of UNAANXDKBXWMLN-UHFFFAOYSA-N.svg
isomerdesign

Sibutramine

Verificar en isomerdesign

pubchem

Sibutramine

Verificar en pubchem

drugmap

Sibutramine

Verificar en drugmap

wiki

Sibutramine

Verificar en wiki

Data

InChI: InChI=1S/C17H26ClN/c1-13(2)12-16(19(3)4)17(10-5-11-17)14-6-8-15(18)9-7-14/h6-9,13,16H,5,10-12H2,1-4H3

Sinónimos: C07247,KBioGR_001653,Sibutramina,SMR000238156,Spectrum3_001009,KBio2_007644,Cyclobutanemethanamine, 1-(4-chlorophenyl)-N,N-dimethyl-alpha-(2-methylpropyl)-,HSDB 7209,SBI-0206737.P001,AKOS022060500,MLS001401362,AC-15773, Reductil (TN),SIBUTRAMINE [MI], Medaria,SIBUTRAMINE [INN],racemic sibutramine,Butramin (TN),SIBUTRAMINE [VANDF],KBio3_001957,Reductil, Sibutramina,CYCLOBUTANEMETHANAMINE, 1-(4-CHLOROPHENYL)-N,N-DIMETHYL-.ALPHA.-(2-METHYLPROPYL)-, N-1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl-N,N-dimethylamine HCl,sibutramine,1-(4-CHLOROPHENYL)-N,N-DIMETHYL-.ALPHA.-(2-METHYLPROPYL)CYCLOBUTANEMETHANAMINE,NCGC00092357-02,Sibutraminum,DTXSID1023578,GTPL2586,Sibutramine (INN),BCP08127,STK802066,D08513,DEA No. 1675,Sibutramina [Spanish], 1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine,Spectrum_001961, Meridia (TN),CCG-101166,( inverted exclamation markA)-Sibutramine,(R)-DDMS, Sibutramine (INN),CAS_106650-56-0, Reductil,106650-56-0,1-[1-(4-Chlorophenyl)cyclobutyl]-N,N,3-trimethyl-butan-1-amine,NCGC00092357-04,Cf-alli,HMS2052P05,Q424151, Sibutramine [INN:BAN],HMS3394P05,HMS2090N17,50S560, Ectiva (TN),KBio2_005076,(+/-)-1-(P-CHLOROPHENYL)-.ALPHA.-ISOBUTYL-N,N-DIMETHYLCYCLOBUTANEMETHYLAMINE,AKOS004119970,SIBUTRAMINE [WHO-DD],(+/-)-Sibutramine, BTS-54524,1-(1-(4-chlorophenyl)cyclobutyl)-N,N,3-trimethylbutan-1-amine,WV5EC51866,SPBio_001612, Meridia,CHEBI:9137,UNII-WV5EC51866, Sibutraminum,NC00416,1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine,Spectrum5_001440,Sibutramine,MLS001066619, Butramin (TN),Butramin,KBioSS_002516,CHEMBL1419,{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}dimethylamine,Spectrum2_001686,BBL010956,Medaria,FT-0674580,Sibutraminum [Latin],DB01105,Sibutramine [INN:BAN],AB00949538-11,(.+/-.)-1-(p-Chlorophenyl)-.alpha.-isobutyl-N,N-dimethylcyclobutanemethylamine,KBio2_002508,Spectrum4_001137, Sibutraminum [Latin], Sibutramina [Spanish],HMS2272C06,BTS 54 524,BSPBio_002737,SCHEMBL2955,AB00949538_12,BDBM84742,NSC_5210

Estimated data

Solubilidad: -4.117 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 97.1% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.